Production (Stage)
E
NeuroPace, Inc. NPCE
$17.68 -$0.19-1.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -25.50% 3.71% 27.44% 15.81% -43.95%
Total Depreciation and Amortization 2.44% 0.00% 1.58% 4.96% 3.42%
Total Amortization of Deferred Charges 0.00% 4.26% -12.96% -30.77% 2.63%
Total Other Non-Cash Items 0.37% 10.22% -22.66% -2.09% 11.77%
Change in Net Operating Assets -45.55% -647.99% 255.68% 86.70% -232.83%
Cash from Operations -55.97% -178.25% 55.79% 48.19% -125.32%
Capital Expenditure 5.13% 61.00% -58.73% 39.42% -225.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- 33.33% -54.55% 32.00% -28.57%
Cash from Investing -101.89% 40.07% -56.75% 35.10% -30.91%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 7,440.64% -68.31% 410.50% -19.42% -91.45%
Repurchase of Common Stock -54,002.17% -35.29% 5.56% 88.91% -1,654.05%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 2,389.15% -70.74% 469.35% 606.94% -99.12%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 783.55% -177.23% 1,771.43% 96.96% -160.66%